Lisa Kitasato

483 total citations
17 papers, 324 citations indexed

About

Lisa Kitasato is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Lisa Kitasato has authored 17 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 6 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in Lisa Kitasato's work include Atrial Fibrillation Management and Outcomes (5 papers), Lipoproteins and Cardiovascular Health (4 papers) and Coronary Interventions and Diagnostics (3 papers). Lisa Kitasato is often cited by papers focused on Atrial Fibrillation Management and Outcomes (5 papers), Lipoproteins and Cardiovascular Health (4 papers) and Coronary Interventions and Diagnostics (3 papers). Lisa Kitasato collaborates with scholars based in Japan, Slovakia and Portugal. Lisa Kitasato's co-authors include Minako Yamaoka‐Tojo, Taiki Tojo, Takehiro Hashikata, Ryo Kameda, Junya Ako, Takao Shimohama, S Namba, Takuya Hashimoto, Kazuhiro Fujiyoshi and Ryota Kakizaki and has published in prestigious journals such as Nature Communications, Biomedicine & Pharmacotherapy and Placenta.

In The Last Decade

Lisa Kitasato

16 papers receiving 315 citations

Peers

Lisa Kitasato

CCM

SURGE

EDM

José Alberto Navarro‐García Spain

Teruhisa Taoka Japan

Stefan‐Martin Brand‐Herrmann Germany

Rick van Gorp Netherlands

Johnny Nehmé France

Michele D’ Amico Italy

Kunihiko Kameda Japan

Hidenori Nishida Japan

H. Carlijne Hassing Netherlands

Jun Zou China

José Alberto Navarro‐García Spain

Lisa Kitasato

165 ×1.4

CCM

168 ×1.8

69 ×0.9

SURGE

38 ×0.7

EDM

59 ×1.2

Citations per year, relative to Lisa Kitasato Lisa Kitasato (= 1×) peers José Alberto Navarro‐García

Countries citing papers authored by Lisa Kitasato

Since Specialization

Citations

This map shows the geographic impact of Lisa Kitasato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Kitasato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Kitasato more than expected).

Fields of papers citing papers by Lisa Kitasato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Kitasato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Kitasato. The network helps show where Lisa Kitasato may publish in the future.

Co-authorship network of co-authors of Lisa Kitasato

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Kitasato. A scholar is included among the top collaborators of Lisa Kitasato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Kitasato. Lisa Kitasato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Naruke, Takashi, Lisa Kitasato, Takeru Nabeta, et al.. (2025). The Role of Esaxerenone in the Continuum of Heart Failure With Preserved Ejection Fraction: Insights From a Prospective Observational Study. Clinical Cardiology. 48(4). e70137–e70137.

Kitasato, Lisa, Minako Yamaoka‐Tojo, S. Nakahara, et al.. (2024). Fibroblasts activation by embryonic signal switching: A novel mechanism of placental growth factor-induced cardiac remodeling. Placenta. 154. 129–136. 1 indexed citations

Kitasato, Lisa, Minako Yamaoka‐Tojo, Yusuke Murayama, et al.. (2024). Rivaroxaban as a Protector of Oxidative Stress-Induced Vascular Endothelial Glycocalyx Damage via the IQGAP1/PAR1-2/PI3K/Akt Pathway. Journal of Vascular Research. 62(1). 1–15. 1 indexed citations

Yamaoka‐Tojo, Minako, et al.. (2022). Association between instrumental activities of daily living frequency and clinical outcomes in older patients with cardiovascular disease. European Journal of Cardiovascular Nursing. 22(1). 64–72. 3 indexed citations

Oikawa, Jun, Hidehira Fukaya, Shunsuke Ishii, et al.. (2022). Variation in Heart Rate Range by 24-h Holter Monitoring Predicts Heart Failure in Patients with Atrial Fibrillation. ESC Heart Failure. 9(5). 3092–3100. 5 indexed citations

Namba, S, Minako Yamaoka‐Tojo, Ryota Kakizaki, et al.. (2017). Effects on bone metabolism markers and arterial stiffness by switching to rivaroxaban from warfarin in patients with atrial fibrillation. Heart and Vessels. 32(8). 977–982. 42 indexed citations

Diguet, Nicolas, Jean‐François Le Garrec, Marta Novotová, et al.. (2017). Amotl1 mediates sequestration of the Hippo effector Yap1 downstream of Fat4 to restrict heart growth. Nature Communications. 8(1). 14582–14582. 77 indexed citations

Hashikata, Takehiro, Taiki Tojo, Yusuke Muramatsu, et al.. (2017). Lower Level of Low Density Lipoprotein Cholesterol is Associated with a Higher Increase in the Fractional Flow Reserve in Patients with Fixed-dose Rosuvastatin. Journal of Atherosclerosis and Thrombosis. 25(3). 233–243. 6 indexed citations

Hashikata, Takehiro, Minako Yamaoka‐Tojo, Ryota Kakizaki, et al.. (2016). Ezetimibe enhances and stabilizes anticoagulant effect of warfarin. Heart and Vessels. 32(1). 47–54. 9 indexed citations

10.

Hashikata, Takehiro, Minako Yamaoka‐Tojo, Ryota Kakizaki, et al.. (2015). Teneligliptin improves left ventricular diastolic function and endothelial function in patients with diabetes. Heart and Vessels. 31(8). 1303–1310. 32 indexed citations

11.

Kitasato, Lisa, Takao Shimohama, Yuki Ikeda, et al.. (2015). Clinical outcomes of chronic kidney disease patients treated with everolimus-eluting stents (EES) and paclitaxel-eluting stents (PES). Biomedicine & Pharmacotherapy. 72. 6–10. 6 indexed citations

12.

Namba, S, Minako Yamaoka‐Tojo, Takehiro Hashikata, et al.. (2015). Long-term warfarin therapy and biomarkers for osteoporosis and atherosclerosis. PubMed. 4. 76–80. 31 indexed citations

13.

Hashikata, Takehiro, Minako Yamaoka‐Tojo, S Namba, et al.. (2015). Rivaroxaban Inhibits Angiotensin II-Induced Activation in Cultured Mouse Cardiac Fibroblasts Through the Modulation of NF-<i>κ</i>B Pathway. International Heart Journal. 56(5). 544–550. 27 indexed citations

14.

Hashikata, Takehiro, Taiki Tojo, S Namba, et al.. (2014). Neointimal coverage of zotarolimus-eluting stent at 1, 2, and 3 months’ follow-up: an optical coherence tomography study. Heart and Vessels. 31(2). 206–211. 19 indexed citations

15.

Kitasato, Lisa, Minako Yamaoka‐Tojo, Takehiro Hashikata, et al.. (2014). Factor Xa in Mouse Fibroblasts May Induce Fibrosis More Than Thrombin. International Heart Journal. 55(4). 357–361. 25 indexed citations

16.

Kameda, Ryo, Minako Yamaoka‐Tojo, Lisa Kitasato, et al.. (2013). Soluble Fms-like Tyrosine Kinase 1 Is a Novel Predictor of Brain Natriuretic Peptide Elevation. International Heart Journal. 54(3). 133–139. 8 indexed citations

17.

Kitasato, Lisa, et al.. (2012). Postprandial hyperglycemia and endothelial function in type 2 diabetes: focus on mitiglinide. Cardiovascular Diabetology. 11(1). 79–79. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact